Transaction in Own Shares November 2009 Activit...
BOUSSARD & GAVAUDAN HOLDING LIMITED
November 2009 TRANSACTION IN OWN SECURITIES ACTIVITY REPORT[1]
+-------------------------------------------------------------------+
| | Share Buy Back | Liquidity |
| | Programme | Enhancement |
| | | Agreement |
|------------------------------------+----------------+-------------|
| Aggregate number of transactions | 21 | 1 |
| conducted in November 2009 | | |
|------------------------------------+----------------+-------------|
| Average size of the transactions | 13,039 | 1,250 |
|------------------------------------+------------------------------|
| Number of shares outstanding | 56,314,718 |
| following such Purchases | |
+-------------------------------------------------------------------+
30 November 2009
For further information please contact:
Emmanuel Gavaudan
Boussard & Gavaudan Asset Management, LP
+44 (0) 207 7514 0700
The Company is established as a closed-ended investment company
domiciled in Guernsey. The Company has received the necessary
approval of the Guernsey Financial Services Commission and the States
of Guernsey Policy Council. The Company is registered with the Dutch
Authority for the Financial Markets as a collective investment scheme
pursuant to article 2:73 in conjunction with 2:66 of the Dutch
Financial Supervision Act (Wet op het financieel toezicht). The
company is listed on Euronext Amsterdam and on the London Stock
Exchange ("LSE").
This announcement is for information purposes only and is not an
offer to invest. All investments are subject to risk. Past
performance is no guarantee of future returns. Prospective investors
are advised to seek expert legal, financial, tax and other
professional advice before making any investment decision. The value
of investments may fluctuate. Results achieved in the past are no
guarantee of future results.
This is not an offer to sell or a solicitation of any offer to buy
any securities in the United States or in any other jurisdiction.
This announcement is not intended to and does not constitute, or form
part of, any offer or invitation to purchase any securities or the
solicitation of any vote or approval in any jurisdiction, nor shall
there be any sale, issuance or transfer of the securities referred to
in this announcement in any jurisdiction in contravention of
applicable law.
Neither the Company nor Sark Fund Limited have been, and neither will
be, registered under the US Investment Company Act of 1940, as
amended (the "Investment Company Act"). In addition the securities
referenced in this announcement have not been and will not be
registered under the US Securities Act of 1933, as amended (the
"Securities Act"). Consequently any such securities may not be
offered, sold or otherwise transferred within the United States or
to, or for the account or benefit of, US persons except in accordance
with the Securities Act or an exemption therefrom and under
circumstances which ill not require the issuer of such securities to
register under the Investment Company Act. No public offering of any
securities will be made in the United States.
[1] This report includes the transactions conducted by both BGHL, for
the share buy back programme and Exane, for the Liquidity Enhancement
Agreement.
http://hugin.info/139558/R/1358159/330594.pdf
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.